AGRX
Agile Therapeutics Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
agile therapeutics is a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today's women. our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. our lead product candidate, twirla®, (ethinyl estradiol and levonorgestrel transdermal system), also known as ag200-15, is a once-weekly prescription contraceptive patch that recently completed phase 3 trials. twirla is based on our proprietary transdermal patch technology, called skinfusion®, which is designed to provide advantages over currently available patches and is intended to optimize patch adhesion and patient wearability. for more information, please visit the company website at www.agiletherapeutics.com. connect with us on twitter at @agilether.
Market Cap: 2.39 Million
Primary Exchange: NASDAQ
Website: https://www.agiletherapeutics.com/
Shares Outstanding: 2.96 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.6644162478225721
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Ethical Flags
Longest drawdown: 2368 trading days
From: 2015-04-16 To: 2023-04-10
Lowest Point:
Roth likes Village Farms in premarket analyst action
via: SeekingAlpha at 2019-06-13 03:36:02:000
Argenx (NASDAQ: AGRX ) initiated with Buy rating and 140 (28% upside) price target at Kepler Cheuvreux. More news on: Agile Therapeutics, Inc., Village Farms International, Inc., Savara Inc., Healthcare stocks news, Stocks on the move, , Read more … read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|